Viriom
8 employees on LinkedIn · 2 known investors
Find your way into Viriom
Sign up to see every warm intro you have to Viriom
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viriom team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Viriom Inc. develops a pipeline of treatments for infectious diseases (blood-borne and respiratory viral diseases) and malignant diseases (solid tumors) through a global drug development platform built with partner networks. The company aims to broaden access to new therapies in both developed and developing countries.
Investors · 2
In the news
Frequently asked questions
- What does Viriom do?
- Viriom Inc. develops a pipeline of treatments for infectious diseases (blood-borne and respiratory viral diseases) and malignant diseases (solid tumors) through a global drug development platform built with partner networks. The company aims to broaden access to new therapies in both developed and developing countries.
- Who are Viriom's investors?
- Viriom's investors include Torrey Pines Investment, Skolkovo Foundation.
